News & Press Releases
Filter by:
Mintz Advises on Protara Therapeutics' $75 Million Public Offering
December 16, 2025
Mintz Advises on Fulcrum Therapeutics' $175 Million Public Offering
December 16, 2025
Mintz advised the underwriters in connection with Fulcrum Therapeutics' $175 million public offering.
Mintz Advises on Wave Life Sciences $402.5 Million Public Offering
December 12, 2025
Mintz advised Wave Life Sciences in its $402.5 million public offering.
Mintz advised Cultivo, a leading platform for developing and operating natural assets at scale, on its acquisition of leading carbon grasslands project developer Kateri.
Mintz Advises SILAC on Acquisition by Hildene Capital Management
December 10, 2025
Mintz advised SILAC, Inc., the parent company of SILAC Insurance Company (“SILAC”), a leading provider of fixed and fixed indexed annuity products in the US, on its definitive agreement to be acquired by Hildene Capital Management, an $18+ billion credit-focused alternative asset manager, for approximately $550 million in cash.
Mintz Advises on Capricor Therapeutics’ $150 Million Public Offering
December 10, 2025
Mintz advised the underwriters in connection with Capricor Therapeutics’ $150 million public offering.
